...
首页> 外文期刊>Anais Brasileiros de Dermatologia >Mucormycosis and chromoblastomycosis occurring in a patient with leprosy type 2 reaction under prolonged corticosteroid and thalidomide therapy
【24h】

Mucormycosis and chromoblastomycosis occurring in a patient with leprosy type 2 reaction under prolonged corticosteroid and thalidomide therapy

机译:长期接受皮质类固醇和沙利度胺治疗的麻风2型反应患者发生毛霉菌病和成色细胞病

获取原文

摘要

Mucormycosis is an uncommon fungal infection caused by Mucorales. It frequently occurs in patients with neutropenia, diabetes, malignancy and on corticoid therapy. However, it is rare in patients with AIDS. Clinical disease can be manifested in several forms. The case reported illustrates the rare occurrence of chromoblastomycosis and mucormycosis in an immunosuppressed patient with multibacillary leprosy, under prolonged corticosteroid and thalidomide therapy to control leprosy type 2 reaction. Neutrophil dysfunction, thalidomide therapy and work activities are some of the risk factors in this case. Chromoblastomycosis was treated by surgical excision and mucormycosis with amphotericin B. Although the prognosis of mucormycosis is generally poor, in the reported case the patient recovered successfully. This case should alert dermatologists to possible opportunistic infections in immunosuppressed patients.
机译:毛霉菌病是由毛霉菌引起的罕见真菌感染。它经常发生于中性粒细胞减少,糖尿病,恶性肿瘤和糖皮质激素治疗的患者中。但是,在艾滋病患者中很少见。临床疾病可以几种形式表现出来。报告的病例说明了在长期使用皮质类固醇和沙利度胺治疗以控制2型麻风反应的情况下,免疫抑制的多细菌性麻风病患者很少发生发色母细胞增多症和毛霉菌病。中性粒细胞功能障碍,沙利度胺治疗和工作活动是这种情况下的一些危险因素。用两性霉素B通过手术切除和毛霉菌病治疗了成色菌病。尽管毛霉菌病的预后一般较差,但在报告的病例中患者已成功康复。这种情况应提醒皮肤科医生注意免疫抑制患者可能的机会性感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号